A clinic visit, hospital admission, or transition in care often begins with medication reconciliation. Developed to provide safer, more coordinated, and better-quality care, medication reconciliation ...

Purpose: The effectiveness of a multidisciplinary medication reconciliation process was studied in an inpatient family medicine unit of an academic hospital center. Methods: In phase 1 of this ...

An effective hospital discharge process created by Cleveland Clinic is pivotal in the handoff of patients to postacute-care providers. Hospital discharge is a complex process involving the primary ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Postdischarge adverse drug event risk is amplified by frequent medication changes, formulary substitutions, and insurance coverage gaps, with wide variability in published incidence estimates and ...

The Agency for Healthcare Research and Quality provides a free, downloadable medications at transitions and clinical handoffs toolkit for medication reconciliation. Medication reconciliation is a ...

The elderly and chronically ill patients are typically challenged with many drugs and complicated dosing regimens, often leading to medication errors. Medication errors are one of the most common ...

Proper medication reconciliation can help prevent adverse drug events by identifying exactly what medications a patient was taking before coming to the hospital and confirming appropriate medication ...

Like other hospital executives, leaders at King’s Daughters Medical Center, a 99-bed community hospital in Brookhaven, Mississippi, 60 miles south of the state capital in Jackson, were concerned that ...

In this reply to the commentary, “A Call for a Statewide Medication Reconciliation Program,” published in the October 2016 issue of The American Journal of Managed Care®, authors discuss a proven and ...

Objective Geriatric patients often face issues related to polypharmacy and adverse drug events. Re-evaluating prescribed medications and considering deprescribing is critical. Medication discrepancies ...

Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors From December 2022 to January 2025, one MRT ...